China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...
WuXi AppTec deal eases pressure from Congress on Penn and CHOP biotech
WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...
China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 million
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
China's WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million
The Financial Times had reported in October, citing people familiar with the matter, that WuXi and WuXi AppTec are planning ...
Merck to buy WuXi Biologics' Irish vaccine facility for $500 million
WuXi Biologics, a Chinese biopharmaceuticals company, announced on Monday the sale of its WuXi Vaccines facility in Ireland ...
Wuxi Biologics Sells Vaccines Ireland Facility for $500M
Wuxi Biologics (Cayman) ( (HK:2269) ) has provided an announcement.
GEN1d
Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-Cell Engager
WuXi upgraded its WuXiBody platform in bispecific antibody discovery to address the growing global demand for these complex ...
ENDPOINTS NEWS2d
WuXi Bi­o­log­ics to sell Irish vac­cine site to Mer­ck for $500M
WuXi Biologics’ subsidiary WuXi Vaccines is divesting a manufacturing facility in Dundalk, Ireland, to Merck for $500 million ...
FiercePharma2d
In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics
In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...
Rapafusyn Pharmaceuticals to Showcase Its Molecular Glue Drug Discovery Platform at WuXi Global Forum
Rapafusyn Pharmaceuticals, a pioneer in non-degrading molecular glue therapeutics, announced today that it will host an executive roundtable at the WuXi Global Forum on January 14, 2025, in San ...